FDA Drug Application (021839) for INCRELEX by IPSEN INC

Back to FDA Applications sponsored by IPSEN INC

Application Number021839
Product Number001
FormINJECTABLE;SUBCUTANEOUS
Dosage40MG/4ML (10MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINCRELEX
Active IngredientMECASERMIN RECOMBINANT



Back to FDA Applications sponsored by IPSEN INC